1 cterium bovis BCG, Mycobacterium leprae, and Mycobacterium fortuitum.

2 n in Drosophila macrophage-like cells, using Mycobacterium fortuitum.

3          Comparison to a similar screen with Mycobacterium fortuitum, a vacuolar pathogen, identified

4 ed the rapidly growing mycobacterial species Mycobacterium fortuitum and M. abscessus.

5        We describe a child with disseminated Mycobacterium fortuitum and M. avium complex infections

6 cedures, were evaluated for activity against Mycobacterium fortuitum and Mycobacterium smegmatis as w

7 obacterium gordonae, Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium scrofulaceum.

8 e identified and investigated an outbreak of Mycobacterium fortuitum furunculosis among customers of

9 with M. peregrinum type I isolates and other Mycobacterium fortuitum group species.

10                           Ten isolates (four Mycobacterium fortuitum group, three Mycobacterium absce

11                    Ten isolates (four of the Mycobacterium fortuitum group, three of Mycobacterium ab

12 % after 3 h, whereas Mycobacterium avium and Mycobacterium fortuitum isolates were unaffected by CB-1

13  24), M. abscessus subsp. abscessus (n = 6), Mycobacterium fortuitum (n = 3), Mycobacterium marseille

14 and were identified as Mycobacterium xenopi, Mycobacterium fortuitum, or Mycobacterium flavescens.

15 (ept) phenotype supported the replication of Mycobacterium fortuitum pAL5000 plasmids.

16                 The regulatory region of the Mycobacterium fortuitum plasmid pAL5000 was studied in v

17 c and clinical similarity to isolates of the Mycobacterium fortuitum third biovariant complex (sorbit